MONOPHARMA logo

MONO Pharmacare Limited

MONOPHARMA·NSE·
8.55 -0.45 (-5.00%)
Market Cap15.90 Cr
PE Ratio4.89
Volume4,000
Day High - Low8.80 - 8.55
52W High-Low25.50 - 7.50
DocStoX Score
4.0/10
Weak
Fair Value
Sign in to see
ROE
9.94%
Average
P/E
4.89x
Cheap
Debt / Equity
1.69
High
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed

Price performance

Day8.55
8.80
52W7.50
25.50
DocStoX take

Supported by valuation (9.0), but held back by momentum (0.0). Valuation looks strong at 9.0, but that is offset by momentum at 0.0. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
4.0
/10
Weak
Quality
Modest
ROE 9.9%
Valuation
Cheap
P/E 4.9×
Growth
Slow
Revenue +35.0% 5Y CAGR
Risk
Elevated
D/E 1.69
Momentum
Weak
6% of 52-week range

At a glance

Market Cap
₹16 Cr
52W High / Low
₹26 / ₹8
Dividend Yield
0.00%
Promoter Holding
56.72%
EPS (TTM)
₹1.75
Book Value
₹17.66

Key highlights

  • Revenue compounding 35% a year
  • Profitable in all of the last 4 years
  • Undemanding at 5× earnings
  • Profit shrinking 2% a year
  • High leverage — debt is 1.7× equity
3 Positives4 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

MONO PHARMACARE LIMITED peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.